HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

10th Edition of World Congress on Infectious Diseases

June 25-27, 2026 | Barcelona, Spain

June 25 -27, 2026 | Barcelona, Spain
Infection 2024

Factors associated with non-adherence to tuberculosis (TB) preventive treatment among adult contacts of pulmonary TB cases with latent TB infection in Spain

Speaker at Infectious Diseases Conferences - Pedro Plans Rubio
College of Physicians of Barcelona, Spain
Title : Factors associated with non-adherence to tuberculosis (TB) preventive treatment among adult contacts of pulmonary TB cases with latent TB infection in Spain

Abstract:

The aim of this study was to identify factors associated with non-adherence to tuberculosis (TB) preventive treatment among contacts with latent TB infection for new cases of pulmonary TB cases reported in Catalonia in 2019–2021. All contacts aged 18 years or older with a latent TB infection who received a TB preventive treatment were included in the study. Multiple logistic regression analysis was used to detect the independent factors associated with TB preventive treatment non-adherence; a p < 0.05 was considered statistically significant. The percentage of non-adherence to TB preventive treatment found in this study was 23.7%. A multivariable logistic regression analysis determined that the following factors were significantly associated with TB preventive treatment non-adherence among adult contacts: “exposure at school or workplace” (aOR = 3.34), “exposure to an index case without laboratory confirmation of TB” (aOR = 2.07), “immigrant contact” (aOR = 1.81), “male gender” (aOR = 1.75) and “exposure duration < 6 h per week or sporadic” (aOR = 1.60. By contrast, the factor “short-term TB preventive treatment regimen” (aOR = 0.38) was significantly associated with a lower treatment non-adherence. Adherence to TB preventive treatment should be improved among adult contacts of TB pulmonary cases with latent TB infection by recommending short-term treatment regimens and by developing health education activities, with a greater focus on contacts with factors associated with treatment non-adherence.

Biography:

Pedro Plans-Rubió has been Responsible for Health Registries, Public Health Agency of Catalonia, Barcelona, Spain (1999-2025). MD from the School of Medicine, University of Barcelona; PhD from the School of Medicine, University of Barcelona; MSc in Health Economics from the School of Economics, University of Barcelona. Specialist in Preventive Medicine and Public Health. Member of the Group of Prioritization of Treatments (GIP), Heath Emergency Preparedness and Response (HERA), European Commission. Member of the Non-communicable diseases risk factor Collaboration (NCD-RisC) research group. Editor-in Chief of Section “Vaccine Advancement, Efficacy and Safety” of journal Vaccines. Member of the Editorial Board of journal Pharmacoeconomics Open, Elsevier.

Watsapp